https://www.prnewswire.com/news-releases/darmiyan-receives-fda-approval-for-brainsee-the-first-prognostic-test-for-predicting-likelihood-of-progression-to-alzheimers-dementia-302033616.html
FDA's De Novo approval of BrainSee represents a major advancement in Alzheimer's diagnostics. Utilizing cutting-edge image processing and medical AI,...
fda approvalthe firstdarmiyanreceivesprognostic